ANNUAL RESULTS
Mankind Pharma Ltd.
BSE
Jul 07, 12:25
2426.00
-13.30 ( -0.55%)
Volume
7783
Prev. Close
2439.30
Open Price
2430.85
Bid Price(Qty.)
2427.55 (4)
Offer Pr.(Qty.)
2430.30 (5)
NSE
Jul 07, 12:14
2420.70
-18.80 ( -0.77%)
Volume
234652
Prev. Close
2439.50
Open Price
2442.50
Bid Price(Qty.)
2420.40 (53)
Offer Pr.(Qty.)
2420.70 (4)
You can view the
Annual Results
for the last 5 years.
|
ISIN No
|
INE634S01028
|
Market Cap. ( ₹ in Cr. )
|
99909.25
|
P/BV
|
9.46
|
Book Value ( ₹ )
|
256.00
|
|
BSE Code
|
543904
|
52 Week High/Low ( ₹ )
|
3055/1901
|
FV/ML
|
1/1
|
P/E(X)
|
50.18
|
|
NSE Code
|
MANKINDEQ
|
Book Closure
|
|
EPS ( ₹ )
|
48.24
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Net Sales/Income from operations | 9497.80 | 9264.81 | 8127.15 | 7486.22 | 5486.16 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 43.44 |
| Total Income From Operations | 9497.80 | 9264.81 | 8127.15 | 7486.22 | 5529.60 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 800.43 | 861.74 | 711.05 | 772.59 | 494.53 |
| Purchase of Traded Goods | 1809.96 | 2071.92 | 1865.82 | 2114.12 | 1541.89 |
| Increase/Decrease in Stocks | -13.50 | -25.36 | 267.89 | -365.27 | -254.25 |
| Employees Cost | 2131.67 | 1982.10 | 1701.38 | 1462.76 | 1106.14 |
| Depreciation | 378.01 | 317.61 | 269.58 | 123.33 | 78.19 |
| Provisions And Contingencies | 15.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 2190.87 | 2049.30 | 1883.64 | 1663.95 | 1263.00 |
| Total Expenses | 7313.26 | 7257.31 | 6699.35 | 5771.48 | 4229.49 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 2184.54 | 2007.50 | 1427.80 | 1714.74 | 1300.11 |
| Other Income | 493.21 | 266.64 | 162.78 | 203.81 | 148.08 |
| P/L Before Interest, Excpt. Items & Tax | 2677.75 | 2274.14 | 1590.58 | 1918.56 | 1448.19 |
| Interest | 371.76 | 14.57 | 27.75 | 47.12 | 7.98 |
| P/L Before Exceptional Items & Tax | 2305.99 | 2259.57 | 1562.84 | 1871.44 | 1440.21 |
| P/L Before Tax | 2305.99 | 2259.57 | 1562.84 | 1871.44 | 1440.21 |
| Tax | 421.74 | 436.16 | 314.58 | 482.01 | 355.83 |
| P/L After Tax from Ordinary Activities | 1884.25 | 1823.41 | 1248.26 | 1389.42 | 1084.37 |
| Extra Ordinary Item | 61.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit/Loss For the Period | 1945.48 | 1823.41 | 1248.26 | 1389.42 | 1084.37 |
| | | | | | |
| Equity Share Capital | 41.26 | 40.06 | 40.06 | 40.06 | 40.06 |
| Reserves And Surplus | 14599.01 | 9560.50 | 7743.85 | 6028.72 | 4694.21 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 48.16 | 45.52 | 31.16 | 34.68 | 27.07 |
| Diluted EPS (Rs.) | 48.07 | 45.45 | 31.16 | 34.68 | 27.07 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 48.16 | 45.52 | 31.16 | 34.68 | 27.07 |
| Diluted EPS (Rs.) | 48.07 | 45.45 | 31.16 | 34.68 | 27.07 |
| | | | | | |
| PBITOE Margin (%) | 23.00 | 21.66 | 17.56 | 22.90 | 23.51 |
| PBTE Margin (%) | 24.27 | 24.38 | 19.22 | 24.99 | 26.04 |
| PBT Margin (%) | 24.27 | 24.38 | 19.22 | 24.99 | 26.04 |
| PAT Margin (%) | 20.48 | 19.68 | 15.35 | 18.55 | 19.61 |